In vitro multispecies Lubbock chronic wound biofilm model

Multispecies biofilms are becoming increasingly recognized as the naturally occurring state in which bacteria reside. One of the primary health issues that is now recognized to be exacerbated by biofilms are chronic, nonhealing wounds such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. Arguably three of the most important species associated with multispecies biofilms that our group sees clinically are Pseudomonas aeruginosa, Enterococcus faecalis, and Staphylococcus aureus. This study was conducted to address the need for a chronic pathogenic biofilm laboratory model that allows for cooperative growth of these three organisms. We have developed a novel media formulation, simple laboratory system, quantitative polymerase chain reaction for monitoring population dynamics, and methods for objectively and subjectively measuring biofilm formation. The Lubbock chronic wound pathogenic biofilm withstood treatment with a 50‐fold higher concentration of bleach than that which was completely bacteriocidal for fully turbid planktonic cultures. The Lubbock chronic wound pathogenic biofilm when treated with biofilm effectors such as gallium nitrate and triclosan responded with selective inhibition of Pseudomonas aeruginosa or Staphylococcus aureus, respectively, as has been reported in the literature. The ability of this 24‐hour model to react as predicted using known biofilm effectors suggests that it will lend itself to future work in the development and testing of first‐generation chronic wounds pathogenic biofilm therapeutics. We have defined a realistic in vitro multispecies biofilm model simulating the functional characteristics of chronic pathogenic biofilms and developed effective tools for its characterization and analyses.

[1]  P. Stewart,et al.  Biofilms in chronic wounds , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[2]  Pradeep K. Singh,et al.  The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. , 2007, The Journal of clinical investigation.

[3]  Blaise R. Boles,et al.  Self-generated diversity produces "insurance effects" in biofilm communities. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D G Smith,et al.  A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. , 1999, Diabetes care.

[5]  Bernhard Guggenheim,et al.  A novel TEM contrasting technique for extracellular polysaccharides in in vitro biofilms , 2007, Microscopy research and technique.

[6]  Costerton Jw Biofilm theory can guide the treatment of device-related orthopaedic infections. , 2005 .

[7]  D. Steinberg,et al.  Sustained-release delivery systems of triclosan for treatment of Streptococcus mutans biofilm. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[8]  T. Phan,et al.  Triclosan inhibition of membrane enzymes and glycolysis of Streptococcus mutans in suspensions and biofilms. , 2006, Canadian journal of microbiology.

[9]  P. Marsh,et al.  The Effects of Triclosan and Zinc Citrate, Alone and in Combination, on a Community of Oral Bacteria Grown in vitro , 1993, Journal of dental research.

[10]  D. E. Saye Recurring and antimicrobial-resistant infections:considering the potential role of biofilms in clinical practice. , 2007, Ostomy/wound management.

[11]  K. Harding,et al.  Bacteria and wound healing , 2004, Current opinion in infectious diseases.

[12]  J. Costerton,et al.  Mechanism of persistent infection associated with peritoneal implants. , 1992, Journal of medical microbiology.

[13]  J. Pulido,et al.  Biofilm and scleral buckle-associated infections. A mechanism for persistence. , 1991, Ophthalmology.

[14]  P. Stewart,et al.  A microtiter-plate screening method for biofilm disinfection and removal. , 2003, Journal of microbiological methods.

[15]  Wagner Fw,et al.  The diabetic foot , 1987 .

[16]  M. J. Meade,et al.  Soil bacteria Pseudomonas putida and Alcaligenes xylosoxidans subsp. denitrificans inactivate triclosan in liquid and solid substrates. , 2001, FEMS microbiology letters.

[17]  Eli N. Perencevich,et al.  Health and Economic Impact of Surgical Site Infections Diagnosed after Hospital Discharge , 2003, Emerging infectious diseases.

[18]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[19]  L. E. Davis,et al.  Biofilm on Ventriculo-Peritoneal Shunt Tubing as a Cause of Treatment Failure in Coccidioidal Meningitis , 2002, Emerging infectious diseases.

[20]  D. Bradshaw,et al.  Microbial film formation: dental plaque deposition on acrylic tiles using continuous culture techniques. , 1987, The Journal of applied bacteriology.

[21]  P. Marsh,et al.  Effect of oxygen, inoculum composition and flow rate on development of mixed-culture oral biofilms. , 1996, Microbiology.

[22]  J. Costerton,et al.  Bacterial biofilms: a common cause of persistent infections. , 1999, Science.

[23]  Scot E. Dowd,et al.  Windows .NET Network Distributed Basic Local Alignment Search Toolkit (W.ND-BLAST) , 2005, BMC Bioinformatics.

[24]  J. Costerton Biofilm theory can guide the treatment of device-related orthopaedic infections. , 2005, Clinical orthopaedics and related research.

[25]  D. Church,et al.  Burn Wound Infections , 2006, Clinical Microbiology Reviews.

[26]  R. White,et al.  Topical antimicrobials in the control of wound bioburden. , 2006, Ostomy/wound management.

[27]  M. Gilmore,et al.  Immunology of Staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis. , 2002, DNA and cell biology.

[28]  S. Percival,et al.  Antimicrobial activity of silver‐containing dressings on wound microorganisms using an in vitro biofilm model , 2007, International wound journal.

[29]  J. Nickel,et al.  Bacterial biofilm in persistent penile prosthesis-associated infection. , 1986, The Journal of urology.

[30]  K. Krogfelt,et al.  Why chronic wounds will not heal: a novel hypothesis , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[31]  J. Costerton Cystic fibrosis pathogenesis and the role of biofilms in persistent infection. , 2001, Trends in microbiology.

[32]  T. Møretrø,et al.  Evaluation of the antibacterial effect of a triclosan-containing floor used in the food industry. , 2006, Journal of food protection.

[33]  K. Beckrich,et al.  Hospital-acquired pressure ulcers: a comparison of costs in medical vs. surgical patients. , 1999, Nursing economic$.

[34]  S. Malekzadeh,et al.  In vivo analysis of bacterial biofilm formation on facial plastic bioimplants , 1998, The Laryngoscope.

[35]  A. Widmer,et al.  Intravascular catheter-associated infections. , 1997, Schweizerische medizinische Wochenschrift.

[36]  D. Stickler,et al.  Effect of Triclosan on the Development of Bacterial Biofilms by Urinary Tract Pathogens on Urinary Catheters , 2022 .

[37]  K. Krogfelt,et al.  Multiple bacterial species reside in chronic wounds: a longitudinal study , 2006, International wound journal.

[38]  J. Nickel,et al.  Ultrastructural microbial ecology of infection-induced urinary stones. , 1985, The Journal of urology.

[39]  G. Onder,et al.  Pressure ulcer and mortality in frail elderly people living in community. , 2007, Archives of gerontology and geriatrics.

[40]  R. Kirsner,et al.  The diabetic foot: The importance of biofilms and wound bed preparation , 2006, Current diabetes reports.